SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.32+1.4%Jan 12 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (4912)11/9/2001 6:15:59 PM
From: Miljenko Zuanic  Read Replies (1) of 52153
 
<<I have just been through the hardcopy Circulation abstracts and caspase inhibition still sticks out as very promising (to me). Needing new eyeballs after the effort, however.>>

Idun did done significant amount of the pre-clinical work. To get some attention they need to move candidate(s) into clinic.

OT:

Any word(s) on Ronalazine data?

Thanks,

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News